Cargando…
Is Th17-Targeted Therapy Effective in Systemic Lupus Erythematosus?
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a broad spectrum of clinical manifestations. The proposed pathophysiological hypotheses of SLE are numerous, involving both innate and adaptive abnormal immune responses. SLE is characterized by the overproduction of different a...
Autores principales: | Petrić, Marin, Radić, Mislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217373/ https://www.ncbi.nlm.nih.gov/pubmed/37232744 http://dx.doi.org/10.3390/cimb45050275 |
Ejemplares similares
-
Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus
por: Yang, Ji, et al.
Publicado: (2016) -
IL-17 in Systemic Lupus Erythematosus
por: Crispín, José C., et al.
Publicado: (2010) -
Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017) -
Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
por: Shah, Kamini, et al.
Publicado: (2010) -
Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New
por: Alunno, Alessia, et al.
Publicado: (2012)